Fatal bleeding in a patient with a non-specific PT and APTT inhibitor.
Krikler
S H
SH
Department of Pathology, University Hospital, Vancouver, BC, Canada.
Carter
C J
CJ
Chonn
A
A
Levitt
D
D
Devine
D V
DV
D000368:Aged; D000369:Aged, 80 and over; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000276:immunology; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology*; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets / Q000502:physiology; D005260:Female; D006474:Hemorrhagic Disorders / Q000209:etiology / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007146:Immunoglobulin lambda-Chains / Q000032:analysis; D008081:Liposomes; D016682:Lupus Coagulation Inhibitor / Q000032:analysis*; D010265:Paraproteinemias / Q000150:complications* / Q000276:immunology; D010314:Partial Thromboplastin Time; D010713:Phosphatidylcholines / Q000276:immunology; D011516:Prothrombin / Q000276:immunology; D011517:Prothrombin Time
D001779:Blood Coagulation Factors; D007074:Immunoglobulin G; D007146:Immunoglobulin lambda-Chains; D008081:Liposomes; D016682:Lupus Coagulation Inhibitor; D010713:Phosphatidylcholines; D011516:Prothrombin